The forest plot drawn according to Cox multivariate regression after incorporating relevant clinical features suggests that the high expression of KDF1, platinum resistance, and primary therapy outcome are risk factors for low OS in patients with ovarian cancer (Figure 3E). This evidence concerns the gene KDF1 and ovarian carcinoma.